As India wrestles with the second wave of COVID-19 and black fungus, a new health condition is posing yet another challenge to the Indian healthcare system: Multi-organ Inflammatory Syndrome (MIS-C). Characterised by inflammation in multiple organs, this condition is affecting COVID-recovered children in our country at an alarmingly increasing rate. Estimates by the Indian Academy of Pediatric Intensive Care reveal that north India alone has reported 100 cases of MIS-C in the last six days. Observed in children in the age bracket of 4-18 years, this condition affects them 4-6 weeks after recovery from COVID-19. Though MIS-C is a disease associated with the SARS-CoV-2 infection, experts are yet to identify a cause-and-effect relationship between the two. Some doctors, however, are of the opinion that it may be an allergy or reaction of the immune system against the antigens that children develop to counter COVID-19.
Though rare, some instances of newborns being hit by MIS-C have also been found. Doctors suggest a 2D Echocardiography in them to rule out heart inflammation. Babies born to mothers who had suffered from COVID-19 in the third trimester should be observed very carefully, say experts.
What is MIS-C?
This is a rare inflammatory disorder, which has increased recently, affecting kids after their recovery from COVID-19. MIS-C emerged in April last year. The result of an overactive immune system, it affects multiple body parts including heart, lungs, brain, kidneys, skin, eyes and digestive organs. In extreme and rare cases, it can result in multi-organ failure and even death. However, a study published in The Lancet Child and Adolescent Health, observes that despite severe symptoms at the initial stage, most of the children recovered within 6 months. The survey was conducted among 46 children in a UK hospital.
Symptoms to watch out for
As already mentioned, MIS-C is an inflammatory disorder that attacks various organs of the body. The major symptoms include:
However, the manifestations may vary from case to case. Inform the doctor in case of emergency signs like breathing trouble, pain in the chest and abdomen, inability to stay awake, skin or lips turning pale, grey or blue.
Diagnosis of MIS-C
Doctors advise the following tests to detect the condition:
Treatment of MIS-C
In most cases, this condition needs hospitalisation. The line of treatment, which aims at symptom control, includes:
Precautionary measures
The safety protocol for MIS-C is very similar to that of COVID-19. Make sure your child: